Cancer-associated venous thrombosis is a common condition, although the reported
incidence varies widely between studies depending on patient population, start and duration …

BACKGROUND Patients with mechanical heart valve prostheses may experience valve
thrombosis and subsequent systemic embolism for which they are treated with oral …

Epidemiological research throughout the last 50 years has provided the long list of risk
factors for venous thrombosis that are known today. Although this has advanced our current …

Background: Estimates of the incidence of venous thrombosis (VT) vary, and data on
mortality are limited. Objectives: We estimated the incidence and mortality of a first VT event …

ContextData on the recurrence rate of venous thrombotic events and the effect of several risk
factors, including thrombophilia, remain controversial. The potential benefit of screening for …

Oral anticoagulant therapy has been shown to be effective for several indications. The
optimal intensity of anticoagulation for each indication, however, is largely unknown. To …

Background The optimal intensity of oral anticoagulant therapy for patients with mechanical
heart valves (ie, the level at which thromboembolic complications are effectively prevented …

Whether an episode of venous thromboembolism (VTE) was unprovoked or provoked by an
environmental (or acquired) risk factor and, if it was provoked, whether the provoking factor …

Importance Excess endogenous cortisol has been linked to venous thromboembolism (VTE)
risk, but whether this relationship applies to exogenous glucocorticoids remains uncertain …

The incidence of chronic thromboembolic pulmonary hypertension (CTEPH) after pulmonary
embolism (PE) is relevant for management decisions but is currently unknown. We …